Before Invest
AbbVie Inc. logo

AbbVie Inc.

ABBV
Pharmaceutical Preparations
Last filing · Quarter 2 · Jun 30, 2026
Financial Statements Ratios
Export XLSX
Unlock 29 quarters
Statement
Period
Annual Quarterly
Order
Format
% Change
Rows
USD ($)
$ in Millions, shares in Millions		Jun 30, 2026Mar 31, 2026Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jun 30, 2017Mar 31, 2017Sep 30, 2016Jun 30, 2016Mar 31, 2016Sep 30, 2015Jun 30, 2015Mar 31, 2015Sep 30, 2014Jun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013Mar 31, 2013
Net revenues
$ 16,990
$ 15,002
$ 15,776
$ 15,423
$ 13,343
$ 14,460
$ 14,462
$ 12,310
$ 13,927
$ 13,865
$ 12,225
$ 14,812
Cost of products sold
4,291
4,218
5,304
4,346
4,002
4,212
4,202
4,094
6,485
4,240
3,986
5,022
Selling, general and administrative
3,632
3,578
3,569
3,253
3,293
4,205
3,377
3,315
3,372
3,268
3,039
3,304
Research and development
2,344
2,472
2,319
2,131
2,067
2,130
1,948
1,939
1,723
1,733
2,292
1,614
Acquired IPR&D and milestones
291
744
2,680
823
248
82
937
164
66
280
150
40
Other operating income
0
-
0
24
-
0
0
0
0
169
10
(229)
Other expense
-
-
-
-
-
-
-
-
-
-
-
-
Total operating costs and expenses
10,558
11,012
13,872
10,529
9,610
10,629
10,464
9,512
11,646
9,352
9,457
10,209
Operating earnings
6,432
3,990
1,904
4,894
3,733
3,831
3,998
2,798
2,281
4,513
2,768
4,603
Interest expense, net
(679)
(645)
(667)
(678)
(627)
(591)
(506)
(453)
(398)
(454)
(454)
(497)
Net foreign exchange loss (gain)
-
-
(20)
(23)
(4)
3
(1)
(4)
(25)
(37)
(35)
(36)
Other expense, net
(1,475)
(2,306)
(503)
(2,639)
(1,441)
(1,159)
(1,345)
(586)
95
(1,412)
(1,804)
330
Earnings before income tax expense
4,278
1,039
714
1,554
1,661
2,084
2,146
1,755
1,953
2,610
475
4,400
Income tax expense
662
342
526
613
372
520
773
383
172
583
234
448
Net earnings
3,616
697
188
941
1,289
1,564
1,373
1,372
1,781
2,027
241
3,952
Net earnings attributable to noncontrolling interest
3
2
2
3
3
3
3
3
3
3
2
3
Net earnings attributable to AbbVie Inc.
$ 3,613
$ 695
$ 186
$ 938
$ 1,286
$ 1,561
$ 1,370
$ 1,369
$ 1,778
$ 2,024
$ 239
$ 3,949
Per share data
                                         
Basic earnings per share (in dollars per share)
$ 2.04
$ 0.39
$ 0.1
$ 0.52
$ 0.72
$ 0.88
$ 0.77
$ 0.77
$ 1
$ 1.14
$ 0.13
$ 2.22
Diluted earnings per share (in dollars per share)
2.03
0.39
0.1
0.52
0.72
0.88
0.77
0.77
1
1.14
0.13
2.21
Cash dividends declared per common share (in dollars per share)
-
-
-
-
-
-
-
-
-
-
-
-
Weighted-average basic shares outstanding (in shares)
1,769
1,770
1,769
1,768
1,768
1,769
1,768
1,769
1,767
1,767
1,770
1,771
Weighted-average diluted shares outstanding (in shares)
1,771
1,774
1,772
1,771
1,772
1,772
1,771
1,773
1,771
1,771
1,776
1,776